The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage

BACKGROUND: Intravitreal injection of anti-vascular endothelial growth factor (VEGF) has become first line therapy for diabetic macular edema. This study evaluated the efficacy and safety of intravitreal injection of Ranibizumab (IVR) as pre-treatment for pars plana vitrectomy in proliferative diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shengguo, Yang, Yan, Zou, Jingling, Zeng, Jun, Ding, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830025/
https://www.ncbi.nlm.nih.gov/pubmed/35139812
http://dx.doi.org/10.1186/s12886-022-02303-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830025/
https://www.ncbi.nlm.nih.gov/pubmed/35139812
http://dx.doi.org/10.1186/s12886-022-02303-3

Ejemplares similares